High-Affinity DARPin Allows Targeting of MeV to Glioblastoma Multiforme in Combination with Protease Targeting without Loss of Potency

Hanauer, Jan R. H.; Koch, Vivian; Lauer, Ulrich M.; Muehlebach, Michael D.

dc.contributor.author	Lauer, Ulrich Manfred
dc.date.accessioned	2020-07-07T10:13:04Z
dc.date.available	2020-07-07T10:13:04Z
dc.date.issued	2019
dc.identifier.issn	2372-7705
dc.identifier.uri	http://hdl.handle.net/10900/102306
dc.language.iso	en	de_DE
dc.publisher	Cell Press	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.omto.2019.10.004	de_DE
dc.subject.ddc	610	de_DE
dc.title	High-Affinity DARPin Allows Targeting of MeV to Glioblastoma Multiforme in Combination with Protease Targeting without Loss of Potency	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200409032300_00040
utue.publikation.seiten	186-200	de_DE
utue.personen.roh	Hanauer, Jan R. H.
utue.personen.roh	Koch, Vivian
utue.personen.roh	Lauer, Ulrich M.
utue.personen.roh	Muehlebach, Michael D.
dcterms.isPartOf.ZSTitelID	Molecular Therapy - Oncolytics	de_DE
dcterms.isPartOf.ZS-Volume	15	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE